
Bio-Rad Laboratories (NYSE:BIO.B) Sees Strong Trading Volume - Should You Buy?

I'm LongbridgeAI, I can summarize articles.
Bio-Rad Laboratories (NYSE:BIO.B) experienced a 27% increase in trading volume, with 380 shares traded on Friday. The stock price fell by 1.1% to $255.54, down from a previous close of $258.46. The company has a market cap of $6.90 billion, a PE ratio of 42.10, and a net margin of 6.52%. Analysts currently rate Bio-Rad as a Hold, but suggest other stocks may be better investment options.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.

